1. FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma
- Author
-
Philippe Trensz, C. Heimburger, Izzie Jacques Namer, Caroline Bund, Stéphane Kremer, and Cecile Fohrer
- Subjects
Male ,medicine.medical_specialty ,Lymphoma, B-Cell ,Nerve root ,Medullary cavity ,medicine.medical_treatment ,Spinal mri ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Autologous stem-cell transplantation ,Fluorodeoxyglucose F18 ,Positron Emission Tomography Computed Tomography ,Marek Disease ,medicine ,Animals ,Humans ,Radiology, Nuclear Medicine and imaging ,B-cell lymphoma ,Neoplasm Staging ,Chemotherapy ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,General Medicine ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Lymphoma ,030220 oncology & carcinogenesis ,Radiology ,business - Abstract
A 46-year-old man with stage IV triple-hit B-cell lymphoma diagnosed in February 2016 was treated with chemotherapy. He was followed classically with FDG PET/CT, which assessed the complete metabolic response in June 2016. In July 2016, he had autologous stem cell transplantation. Two months later, he underwent an FDG PET/CT for revaluation. It showed intense FDG uptake in the medullary canal from cervical 4 to thoracic 4, bilateral cervical 7 to thoracic 8, and right thoracic 9 to 12 nerve roots, leading to the diagnosis of neurolymphomatosis. A clinical cervical radiculopathy and spinal MRI results reinforced this diagnosis.
- Published
- 2017
- Full Text
- View/download PDF